Payer Engagement Director

The Payer Engagement (PE) Director role will have accountability for delivering this change and for helping to secure national access for an unprecedented number of new assets launches over the next 5 years. They will be accountable for developing and maintaining relationships of the most critical order across the NHS, directly resulting in national access. Our evolving portfolio means that most of these launches will be in highly complex and specialised areas (specialist, oncology and vaccines), where the external UK market access landscape has recently undergone huge reform. The role will oversee the complete transformation of our market access approach to payer engagement in the UK. The PE Director plays a crucial role in developing and nurturing senior operational relationships with external stakeholders, including NHS England and private providers. The postholder will serve as the primary point of contact for negotiations, ensuring that our partnerships are strong and mutually beneficial. Additionally, the postholder will be responsible for defining the strategic account management approach needed to effectively deliver on both our portfolio and business unit priorities at a national, regional, and cluster level as required. This approach will be delivered through effective partnering with the wider UK business and leading a motivated and capable team of strategic account managers. The PE Director develops and leads the Market Access strategy in respect of payer engagement. The postholder will work with our global and local teams to ensure to find solutions to complex market access and pathway problems. They will be responsible for developing and maintaining relationships with key external stakeholders (His Majesties Government- HMG, Devolved Administrations - DA, National Health Service England - NHSE, Medicines and Healthcare Products Regulatory Agency - MHRA, National Institute of Clinical Excellence -NICE, Scottish Medicines Consortium - SMC, All Wales Medicines Strategy Group - AWMSG) to develop GSK positions, maximise the value our medicines bring to patients and ensure the broadest possible access.,

• As a senior member of the UK HVA Market Access (MA) team, act as leadership team member and strategic advisor and business partner to BU Heads, provide strategic Market Access input to key business decisions to drive commercial / reputational success for the GSK UK business. Providing strategic advice and counsel to the Head of Market Access, VP, Health Value and Access and his/her leadership team across all business unit matters - in particular, market access, payer engagement, government policy development and the external environment as it relates to UK Commercial business unit and UK Market Access strategy development and execution.
• Effective strategic stakeholder management with key external partners including but not limited to national trade associations, HMG, local, regional, and national commissioning bodies (e.g. NHSE), regulatory and HTA bodies (MHRA, NICE, SMC, AWMSG etc.
• Build and lead the MA Payer Engagement function to ensure value of GSK medicines is understood and received by external customers and GSK reputation is protected. leadership of the strategic account management strategy and its implementation via a team of SAMs. Creating a network of subnational relationships with senior population level decision makers to enable effective and efficient engagement regarding above therapy collaborative opportunities as well as gatekeeping therapy specific discussion opportunities for the wider account management teams.
• Thorough understanding of the NHS landscape and the factors that influence its decision-making processes, and ability to overlay this with how best to position our pipeline assets through MA and HVA activity & utilising insights from The Hub. Defines overall strategy for NHSE approach, validates across GSK UK and ensures HO, CGA, BU and medical are all operating in step with this strategy.
• Fully accountable for MA programs to deliver our commercial forecast. Overseeing commercial negotiations with NHS England (including the Cancer Drugs Fund and Innovative Medicines Fund) and other stakeholders to obtain optimal access and pricing outcome for GSK assets. Leading the development of optimal pricing and market access strategy at national and sub-national levels aligned to brand strategy across the GSK portfolio. Lead the development of business cases to support approval of UK pricing and market access strategy. Lead the support for business unit and pricing teams in tender submissions
• Monitor, evaluate, interpret and predict the changing internal and external environments and proactively consider the implications/impact (e.g., threats and opportunities, financial and reputational impact) on current and future business unit and functional strategy, company reputation and employee motivation, advising the business on appropriate action to manage the impact.
• Cohesive pricing strategy: Responsible for creating negotiation dossiers to enable success with Payers and maintains the pricing model for existing products, incorporates value-based pricing strategies, partners with HO and medical.
• Play a crucial role in guiding the price strategy for entry, exit, and maintenance of a medicine
• Establishing and managing the required internal control framework (ICF) elements to ensure effective risk management, governance and compliance., We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on Ukdiversity.recruitment@gsk.com or . Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a UK Recruitment FAQ guide. Click the link and scroll to the Careers Section where you will find answers to multiple questions we receive . As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially. Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site. Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit GSK's Transparency Reporting For the Record site.

We are looking for professionals with these required skills to achieve our goals:
• Educated to degree (equivalent level) with a life sciences qualification or other relevant qualifications.
• Systematic understanding of the NHS landscape across 4 nations and the factors that influence its decision-making processes and operational pathway design development.
• Demonstrated leadership experience of a market access team and extensive experience as a strategic advisor to UK Leadership Team or business partners.
• Proven senior stakeholder management and influencing skills with the ability to solve complex issues.
• Considerable experience gained from the pharmaceutical industry or in an NHS/government role especially in commercial and/or access area.
• Strong complex issues management and delivery experience in market access including development and delivery of nationally impactful MA programs.
• Evidence of understanding of HMG, NHS, NGOs, Trade Associations and their ability to partner and deliver meaningful change within UK environment.
• Relevant experience of market access; bringing medicines through the pricing and reimbursement process as well as driving access and uptake across multiple therapy areas at national and regional level., Advanced degree such as a PhD or MBA in a relevant field.
• Politically savvy with proven ability to comprehend issues from a UK legislative, regulatory and policy prospective.
• Ability to interpret how outside stakeholders view and understand the organisation, its products and services.
• Ability to develop strategy which connects a company action with a diverse set of ever-expanding stakeholders
• Gravitas and confidence to be the truth teller, even when the message is uncomfortable
• High personal accountability and integrity combined with the ability and experience to influence at a strategic level and gain the support and commitment of internal and external stakeholders
• Excellent business acumen and demonstrated sustained level of delivery of performance.
  
  GSK has bold commercial ambitions for the future. By 2031, we aim to deliver £38 billion in annual sales - building from existing strong performance momentum which will significantly increase the positive impact we can have on the health of billions of patients around the world. Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems. Our portfolio is made up of vaccines, specialty medicines and general medicines. These are the three different types of products we create to prevent and treat disease, many with the potential to be first-or best-in-class., Why GSK?
Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves - feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.